Product name: GNRH TRIPTORELIN
Manufacturer: Magnus Pharmaceuticals
0,00 € Shipping
0,00 € Total
Product: Test-Prop 100Manufacturer:...
Pharmaceutical name: Test. Cypionate...
One vial of 10ml (100mg/ml)
Pharmaceutical name: trenbolone...
Pharmaceutical name: Testosterone...
GNRH Triptorelin Peptide Magnus Pharmaceuticals:
GNRH Triptorelin Peptide Magnus Pharmaceuticals can be an effective way to „kickstart“ the body‘s testosterone production at exact doses after a steroid (anabolic) cure. Or generally a PCT simplify and abbreviate.
GNRH Triptorelin Peptide Magnus Pharmaceuticals is a synthetic analogue to the so-called gonadotropin releasing hormone (GnRH or gonadoliberin) and acts as a GnRH agonist. Triptorelin ensures that the pituitary gland distributes smaller amounts of the hormones LH and FSH. This has the direct consequence that the secretion of sex hormones such as testosterone is stimulated. Reduced by long-term use of triptorelin (more than 2 weeks).
In the normal case, uses GNRH Triptorelin Peptide Magnus Pharmaceuticals for the treatment of various types of cancer, such as prostate cancer, or for the treatment of sexual identity disorders. Or can be applied to women in advance of artificial insemination in order to increase the chances of success.
For use as a means for PCT or for a complete restart of testosterone production after a shutdown. For which this peptide is also interesting, GNRH Triptorelin Peptide Magnus Pharmaceuticals should not be overdosed (maximum 100 mcg), since otherwise it can be very likely that a (temporary) chemical castration occurs.
GNRH Triptorelin Peptide Magnus Pharmaceuticals general information about :
In general, GnRH agonists (such as triptorelin, sequence: pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2) are used when the end of the target is a reduction in the amount of sex hormones circulating in the body Therapeutic reasons. This is the case, for example, with certain types of cancer, such as breast cancer or prostate cancer. GnRH agonists force the hypophysis to release hormones FSH (follicular stimulating hormone) and LH (luteinizing hormone) in excessive amounts. This mechanism first leads to excessive secretion of sex hormones such as estrogen or testosterone (whose secretion is influenced by FSH and LH, respectively) until the pituitary gland has exhausted its natural supply of FSH and LH due to overstimulation, leading to sustained lower serum levels of these sex hormones leads.
GnRH agonists such as GNRH Triptorelin Peptide Magnus Pharmaceuticals are not only used for hormone-dependent cancer. Also with early puberty in children, with gender identity disturbances or also in the framework of artificial fertilizations, GNRH Triptorelin Peptide Magnus Pharmaceuticals is frequently used. Therefore, GNRH Triptorelin Peptide Magnus Pharmaceuticals is also a substance whose effects and side effects have been well explored for many years.
But even in the case of really well researched substances, scientists sometimes find interesting new applications that were not originally thought of.
Pharmacodynamics related to that product
After the first administration of the product, the first effect is in the level of the follicle-stimulating hormone, luteinizing hormone, estradiol and testosterone level into the body. The peak of the testosterone and its decline after the administration of the drug depends on its amount which was administered. This product's initial effects may include the symptoms related to prostate cancer, urethral or bladder related diseases, bone pain, also involved in the injury of the spinal cord. The use of that product may lead to the decreased level of the follicle-stimulating hormone as well as of the luteinizing hormone and also involved in the reduction of the testicular steroidogenesis. The above mention effects are obtained in only 2-4 weeks after its use. This results in the reduction of the testosterone level into the body, especially in the castrated surgery-related men. In the end, the tissues which require these hormones for their proper functioning becomes inactive because they do not get hormones for their proper functioning. These negative side effects related to that product could be reversed after quitting the drug.
Mechanism of action of that product
For the gonadotrophin-releasing hormones, this product acts as the agonist analog. Comparative studies between triptorelin and GnRH show that triptorelin had more profound effects as compare to the other one like this product has 13 folds higher release activity for the luteinizing hormone and 21 folds more higher releasing of the follicle-stimulating hormone. This product is effective in its use.
GNRH Triptorelin Peptide Magnus Pharmaceuticals dosage:
At higher doses of 2 to 4 mg once a month, GNRH Triptorelin Peptide Magnus Pharmaceuticals can also be used as a means of long-term chemical castration. Which for most readers, however, should not be an attractive application. If one wants to use GNRH Triptorelin Peptide Magnus Pharmaceuticals as a means for the PCT, an injection of 100 mcg GNRH Triptorelin Peptide Magnus Pharmaceuticals is sufficient.
If you want to carry out a PCT more than once in one year and plan to use GNRH Triptorelin Peptide Magnus Pharmaceuticals. Should be between the individual applications a period of at least 4 months. One should never inject more than 300 mcg of GNRH Triptorelin Peptide Magnus Pharmaceuticals (max. 100 mcg every 4 months) per year as otherwise the risk of a drop in the serum concentration of testosterone to catastrophic values is higher at higher doses.
yophilized powder, use can be made of sterile water. Since the reconstituted solution does not have to be stored but is injected directly at once. As a rule, only sterile water has to be introduced into the vial in such a way that the reconstituted triptorelin solution resulting from it can completely fill the standing cannula for the injection. Normally 1 to 2 ml of sterile water should be sufficient.
If you want to perform a PCT with GNRH Triptorelin Peptide Magnus Pharmaceuticals, you should not use SERMs like clomifene, raloxifene or tamoxifen. Also hCG should not be used simultaneously with GNRH Triptorelin Peptide Magnus Pharmaceuticals. Ordinary testosterone boosters, e.g. DAA can be administered as usual in the weeks following the GNRH Triptorelin Peptide Magnus Pharmaceuticals injection.
For the reconstitution of the peptide normally present as a l
GNRH Triptorelin Peptide Magnus Pharmaceuticals mix & blend:
GNRH Triptorelin Peptide Magnus Pharmaceuticals is supplied as a freeze-dried powder in the glass vial. This does not have to be cooled yet. Add to your Peptide GNRH Triptorelin Peptide Magnus Pharmaceuticals with 2mg of active ingredient 2ml parenteral water into the vial. Now you have 2ml with 2,000mcg of active ingredient. 1ml with 1000mcg active substance = 0.1ml with 100mcg active substance. The finished peptide is injected with insulin injections. The now ready-to-use GNRH Triptorelin Peptide Magnus Pharmaceuticals active ingredient (liquid) can now be stored in the fridge for weeks as described on the packaging.
GNRH Triptorelin Peptide Magnus Pharmaceuticals possible side effects:
GNRH Triptorelin Peptide Magnus Pharmaceuticals is a peptide which, due to its strong influence on the hormone system of the human body, can have some side effects, even if the number of side-effects actually occurring should be very limited.
All the side effects listed below only occur when GNRH Triptorelin Peptide Magnus Pharmaceuticals is used in the long term and therefore the human organism is exposed to a higher dose:
Essentially, these side effects are only listed here if someone is looking for the side effects of GNRH TriptorelinPeptide Magnus Pharmaceuticals for longer-term use and these are not relevant for the target group actually addressed here.
However, the following side effects can be relevant, since, if these occur, an emergency physician should be consulted: